Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinlan Tiaozhi Capsule in Primary Hyperlipidemia
CTR20190061Phase 2Active
- Sponsor
- Guangdong Provincial Institute of Traditional Chinese Medicine
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Yinlan Tiaozhi in familial hyperlipidemia, sponsored by Guangdong Provincial Institute of Traditional Chinese Medicine. Started Jan 2019; status: active.
02
Drugs
Yinlan Tiaozhi
03
Conditions
familial hyperlipidemia
Beyond the preview
Go deeper on CTR20190061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190061.